UBS report suggests another capital raising may be a risk.
Given December quarter production is also likely to be weak the broker sees scope for additional raisings to be required. Neutral rating is retained. 12 month Target $0.15
- Forums
- ASX - By Stock
- PLA
- ok, ok.. may live to regret it
ok, ok.. may live to regret it, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online